Ranitidine use, N-Nitrosodimethylamine (NDMA) production and variations in cancer diagnoses

Lior Z. Braunstein, Elizabeth D. Kantor, Kelli O’Connell, Amber Hudspeth, Kaury Kucera, Qian Wu, David Y. Light
doi: https://doi.org/10.1101/2021.01.27.21250656

Article Information

doi 
https://doi.org/10.1101/2021.01.27.21250656
History 
  • January 29, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Lior Z. Braunstein, MD1,*,
  2. Elizabeth D. Kantor, PhD1,
  3. Kelli O’Connell, MSPHc1,
  4. Amber Hudspeth, MSc2,
  5. Kaury Kucera, PhD2,
  6. Qian Wu, PhD2 and
  7. David Y. Light, BSc2
  1. 1Memorial Sloan Kettering Cancer Center, New York, NY
  2. 2Valisure LLC, New Haven, CT
  1. ↵*Correspondence: Lior Z. Braunstein, MD, Memorial Sloan Kettering Cancer Center, 1275 York Ave – Box 22, New York, NY 10065, Email: BRAUNSTL{at}mskcc.org
Back to top
Posted January 29, 2021.
Download PDF
Data/Code
Email
Ranitidine use, N-Nitrosodimethylamine (NDMA) production and variations in cancer diagnoses
Lior Z. Braunstein, Elizabeth D. Kantor, Kelli O’Connell, Amber Hudspeth, Kaury Kucera, Qian Wu, David Y. Light
medRxiv 2021.01.27.21250656; doi: https://doi.org/10.1101/2021.01.27.21250656
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area